Market Tracker

10/31 6:04pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.8951
Data as of 2:16pm ET
 -0.0249 / -2.71%
Today’s Change
0.78
Today|||52-Week Range
1.83
-22.84%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.92
Today’s open0.92
Day’s range0.86 - 0.93
Volume363,238
Average volume (3 months)546,095
Market cap$40.6M
Dividend yield--
Data as of 2:16pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.5
Price/Sales1.47
Price/Book7.72

Competitors

 Today’s
change
Today’s
% change
NBYNovaBay Pharmaceutic...-0.01-1.24%
HTBXHeat Biologics Inc+0.11+1.72%
CEMIChembio Diagnostics ...-0.02-0.40%
ANTHAnthera Pharmaceutic...-0.01-0.53%
Data as of 2:29pm ET, 10/31/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts